• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

david.routledge@unimelb.edu.au

Credentials


Position
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0002-9701-3216

Dr David Routledge

Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology

52 Scholarly works
0 Projects

HIGHLIGHTS

  • 2025

    Journal article

    Introduction to the 2024 Consensus Guidelines for the Management of Neutropenic Fever in Patients with Cancer: Principles & Practice of Neutropenic Fever
    DOI: 10.1111/imj.70237
  • 2025

    Journal article

    Consensus guidelines for ambulatory care for neutropenic fever
    DOI: 10.1111/imj.70251
  • 2025

    Journal article

    Best practice points for antimicrobial stewardship and infection prevention: a multidisciplinary approach to supportive care in patients with neutropenic fever
    DOI: 10.1111/imj.70247
  • 2025

    Journal article

    Steering Committee Members.
    DOI: 10.1111/imj.70323
  • 2025

    Journal article

    Primary analysis of the phase 3 randomized trial of selinexor and lenalidomide versus lenalidomide alone as maintenance therapy post autologous stem cell transplant for patients with newly diagnosed multiple myeloma (ALLG MM23; SEALAND)
    DOI: 10.1182/blood-2025-4039
  • 2025

    Journal article

    Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice
    DOI: 10.1016/j.eclinm.2025.103161
  • 2025

    Journal article

    Aligning kidney function assessment in patients with cancer to global practices in internal medicine
    DOI: 10.1016/j.eclinm.2025.103102
David Routledge

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers
    DOI: 10.1111/cts.70144
  • 2025

    Journal article

    Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial
    DOI: 10.1016/S2352-3026(24)00317-X
  • 2024

    Conference Proceedings

    AT FIRST SIGHT - WHAT ADOLESCENTS AND YOUNG ADULTS ARE TELLING US AT FIRST VISIT TO ADULT LONG TERM FOLLOW UP

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224